---
figid: PMC3798933__nutrients-05-03757-g002
figtitle: Insulin signaling pathways are inhibited by damage-associated molecular
  pattern (DAMP)-mediated, Toll-like receptor (TLR)-mediated pathways
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Mycobacterium tuberculosis
pmcid: PMC3798933
filename: nutrients-05-03757-g002.jpg
figlink: /pmc/articles/PMC3798933/figure/nutrients-05-03757-f002/
number: F2
caption: Insulin signaling pathways are inhibited by damage-associated molecular pattern
  (DAMP)-mediated, Toll-like receptor (TLR)-mediated pathways. TLR2/TLR1, TLR2/TLR6
  and TLR4/MD-2 activate both nuclear factor-κB (NF-κB) and mitogen activated protein
  kinase (MAPK) pathways by recognition of various DAMPs. Suppressor of cytokine signaling
  (SOCS)-3, protein tyrosine phosphatase (PTP)-B1 and MAPKs such as c-Jun N-terminal
  kinase (JNK) 1 inhibit insulin receptor substrate (IRS) 1/2 phosphorylation of insulin
  receptors. Signaling via Radioprotective 105 (RP105)/myeloid differentiation protein-1
  (MD-1) may activate the NF-κB pathway, but precise RP105-mediated mechanisms and
  the contribution to adipose tissue inflammation remain unclear.
papertitle: Activation and Regulation of the Pattern Recognition Receptors in Obesity-Induced
  Adipose Tissue Inflammation and Insulin Resistance.
reftext: Yasuharu Watanabe, et al. Nutrients. 2013 Sep;5(9):3757-3778.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9288804
figid_alias: PMC3798933__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Bos taurus
redirect_from: /figures/PMC3798933__F2
ndex: 6eba03cc-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3798933__nutrients-05-03757-g002.html
  '@type': Dataset
  description: Insulin signaling pathways are inhibited by damage-associated molecular
    pattern (DAMP)-mediated, Toll-like receptor (TLR)-mediated pathways. TLR2/TLR1,
    TLR2/TLR6 and TLR4/MD-2 activate both nuclear factor-κB (NF-κB) and mitogen activated
    protein kinase (MAPK) pathways by recognition of various DAMPs. Suppressor of
    cytokine signaling (SOCS)-3, protein tyrosine phosphatase (PTP)-B1 and MAPKs such
    as c-Jun N-terminal kinase (JNK) 1 inhibit insulin receptor substrate (IRS) 1/2
    phosphorylation of insulin receptors. Signaling via Radioprotective 105 (RP105)/myeloid
    differentiation protein-1 (MD-1) may activate the NF-κB pathway, but precise RP105-mediated
    mechanisms and the contribution to adipose tissue inflammation remain unclear.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - TLR1
  - TLR4
  - LY96
  - CD180
  - TLR6
  - LY86
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - IRS2
  - IRS1
  - MYD88
  - TRIM69
  - TICAM1
  - XYLT2
  - SOS1
  - SOS2
  - IRAK1
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - PI3
  - KRAS
  - HRAS
  - NRAS
  - TRAF6
  - TRAF3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP3K7
  - NR2C2
  - SOCS3
  - PTPN1
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IRF3
  - Tlr2
  - Tlr1
  - Tlr4
  - Ly96
  - Gpr83
  - Cd180
  - Tlr6
  - Ly86
  - Shc1
  - Irs2
  - Irs1
  - Myd88
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Irak1
  - Ralbp1
  - Ripk1
  - Serpina1c
  - ras
  - Hras
  - Kras
  - Rem1
  - Traf6
  - Traf3
  - Zhx2
  - Nr2c2
  - Map3k7
  - Socs3
  - Ptpn1
  - Nfkb1
  - Akt1
  - Mapk3
  - Irf3
  - lauric acid
  - palmitate
  - Cancer
  - Noonan syndrome
---
